Great Lakes Advisors, LLC Genprex, Inc. Transaction History

Great Lakes Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$2.59 - $3.36 $28,370 - $36,805	-10,954 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$3.11 - $4.87 $9,846 - $15,418	-3,166 Reduced 22.42%	10,954 $37,000
Q1 2021 May 03, 2021	BUY	$3.66 - $7.67 $51,679 - $108,300	14,120 New	14,120 $61,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $76.8M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Great Lakes Advisors, LLC with notifications on news.